Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »
Tag: oit
FARE Retreat: Experts Explore Food Allergy Treatment, Testing
“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »
Europe’s Palforizia OIT Study Shows Speed of Desensitization
Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Learning More About Oral Immunotherapy for Food Allergy
Allergist Dr. Michael Manning explains how oral immunotherapy (OIT) for food allergy works and shares his experience working with families to ease anxiety.
Palforzia OIT Study Sees Maturing of Immune System Over Time
A study found encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial participants… Read more »
Allergists See Palforzia Starting New Era of Food Allergy Therapy
Allergists that Allergic Living contacted are excited about the FDA’s approval of the first-ever therapy for a food allergy. They… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31, 2020 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy… Read more »
Milk Allergy 101: High Rates in Kids, Strict Avoidance and Future Therapies
The essential facts on milk allergy: from high rates in kids, to strict avoidance, the benefits in baked milk and… Read more »
Panel Backs FDA Approval for Aimmune’s Peanut OIT Drug
An expert advisory panel has recommended that the Food and Drug Administration approve Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for… Read more »
Concerns Raised as ICER Report Praises Peanut Avoidance vs. Therapy
In its final report analyzing the costs and benefits of two novel peanut allergy desensitization products, the Institute for Clinical… Read more »